Delivery Order SPE2DB22D3301-SPE2DB23FZ1HB
Award Date 7/14/23
Potential Completion Date 8/4/23
Potential Value $2.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,075.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on July 21, 2023. The delivery order provides a specified quantity of the Zoladex implant to...
- The Defense Logistics Agency awarded a $5,578.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 3, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,018.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 10, 2026. This non-set-aside delivery order was awarded on January 20, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a contract ceiling value of $37,190. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,789.25 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of October 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the procurement was open to all qualified vendors. This delivery order is...
- The Defense Logistics Agency awarded a $11,757.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of November 10, 2025. This non-set-aside contract was competitively awarded on October 20, 2025, with performance to be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,383.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. The implants will be provided under contract number 4561617893 and delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 15, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supplies medical materials to support the military health system. This delivery order for...
- The Defense Logistics Agency awarded a delivery order valued at $6,055.80 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 26, 2026. This is a firm fixed-price, non-set-aside contract executed on February 4, 2026, with performance taking place at the awardee's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $25,379 delivery order contract to Amerisourcebergen Drug Corporation for the supply of Zoladex 10.8 mg implant syringes. As the prime contractor, Amerisourcebergen will provide the specified pharmaceutical products for use by the Department of Defense from its facility in Conshohocken, Pennsylvania. The firm fixed price contract runs from August 15, 2023 to September 6, 2023 and was issued under an existing DLA pharmaceutical supply vehicle. No...
- The Defense Logistics Agency awarded a delivery order valued at $9,297.50 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This contract, awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zoladex is a hormone treatment used...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ1HBDelivery Order
The Defense Logistics Agency awarded a $2,537.94 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. The delivery order was issued under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by August 4, 2023. No set aside designation or subcontractors were identified. This order supports DLA's mission to provide logistics support for medical supplies to the Military Health System and combatant commands.
Generated 12/17/23, 9:19 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/14/23 |